Literature DB >> 23024839

Overview of resistant hypertension: A glimpse of the cardiologist's current standpoint.

Luis Paiva1, Maria Carmo Cachulo, Rui Providencia, Sergio Barra, Paulo Dinis, Antonio Leitao-Marques.   

Abstract

Hypertension is a major risk factor for cardiovascular disease, resulting in increased incidence of cerebrovascular events, ischaemic heart disease, heart failure, and renal impairment. Thus, it is one of the most important preventable causes of premature morbidity and mortality. Despite current knowledge on the management of hypertension and the availability of several effective antihypertensive medications, uncontrolled hypertension remains a common and challenging clinical problem. Resistant hypertension is a complex condition with multiple contributing factors and overlapping comorbidities. Although there is limited hard evidence regarding resistant hypertension, our understanding of this condition has improved recently. This article will present an overview of resistant hypertension and highlight recent publications about this topic.

Entities:  

Keywords:  Hypertension; Management; Resistant hypertension

Year:  2012        PMID: 23024839      PMCID: PMC3460222          DOI: 10.4330/wjc.v4.i9.275

Source DB:  PubMed          Journal:  World J Cardiol


  39 in total

Review 1.  Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.

Authors:  Michel Azizi; Joël Ménard
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

2.  Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Authors:  Michael E Ernst; Barry L Carter; Chris J Goerdt; Jennifer J G Steffensmeier; Beth Bryles Phillips; M Bridget Zimmerman; George R Bergus
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

3.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Authors:  J N Cohn; G Tognoni
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

4.  Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension.

Authors:  Ramón C Hermida; Diana E Ayala; Carlos Calvo; José E López; Artemio Mojón; María J Fontao; Rita Soler; José R Fernández
Journal:  Hypertension       Date:  2005-08-08       Impact factor: 10.190

5.  Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

Authors:  M Burnier; M P Schneider; A Chioléro; C L Stubi; H R Brunner
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

6.  Is resistant hypertension really resistant?

Authors:  M A Brown; M L Buddle; A Martin
Journal:  Am J Hypertens       Date:  2001-12       Impact factor: 2.689

7.  Heritability of daytime ambulatory blood pressure in an extended twin design.

Authors:  Nina Kupper; Gonneke Willemsen; Harriëtte Riese; Daniëlle Posthuma; Dorret I Boomsma; Eco J C de Geus
Journal:  Hypertension       Date:  2004-11-22       Impact factor: 10.190

8.  Sequential nephron blockade breaks resistance to diuretics in edematous states.

Authors:  H Knauf; E Mutschler
Journal:  J Cardiovasc Pharmacol       Date:  1997-03       Impact factor: 3.105

9.  Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Authors:  Mari Konishi Nishizaka; Mohammad Amin Zaman; David A Calhoun
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

10.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Authors:  John J V McMurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.